The role of surgery in clinical management of patients with metastatic papillary renal cell carcinoma

[1] Beck SD(2004)Effect of papillary and chromophobe cell type on disease-free survival after nephrectomy for renal cell carcinoma Ann Surg Oncol 11 71-77

[2] Patel MI(2003)Comparisons of outcome and prognostic features among histologic subtypes of renal cell carcinoma Am J Surg Pathol 27 612-624

[3] Snyder ME(2008)Efficacy of Sunitinib and Sorafenib in metastatic papillary and chromophobe renal cell carcinoma J Clin Oncol 26 127-131

[4] Kattan MW(2009)Effect of temsirolimus versus interferon-a on outcome of patients with advanced renal cell carcinoma of different tumor histologies Med Oncol 26 202-209

[5] Motzer RJ(2007)Sorafenib in advanced clear-cell renal-cell carcinoma N Engl J Med 356 125-134

[6] Reuter VE(2005)Multiinstitutional European validation of the 2002 TNM staging system in conventional and papillary localized renal cell carcinoma Cancer 104 968-974

[7] Russo P(2002)Expression profiling in human renal carcinomas with functional taxonomic analysis BMC Bioinformatics 3 26-39

[8] Cheville JC(1994)Mutation of the VHL tumour suppressor gene in renal carcinoma Nat Genet 7 85-90

[9] Lohse CM(2005)Histologic subtyping and nuclear grading of renal cell carcinoma and their implications for Survival: a retrospective nation-wide study of 629 patients Eur Urol 48 593-600

[10] Zincke H(2007)Histologic subtype of metastatic renal cell carcinoma predicts response to combined immunochemotherapy with Interleukin 2, Interferon alpha and 5-Fluorouracil Eur Urol 51 1625-1632

[1] Beck SD(2004)Effect of papillary and chromophobe cell type on disease-free survival after nephrectomy for renal cell carcinoma Ann Surg Oncol 11 71-77

[2] Patel MI(2003)Comparisons of outcome and prognostic features among histologic subtypes of renal cell carcinoma Am J Surg Pathol 27 612-624

[3] Snyder ME(2008)Efficacy of Sunitinib and Sorafenib in metastatic papillary and chromophobe renal cell carcinoma J Clin Oncol 26 127-131

[4] Kattan MW(2009)Effect of temsirolimus versus interferon-a on outcome of patients with advanced renal cell carcinoma of different tumor histologies Med Oncol 26 202-209

[5] Motzer RJ(2007)Sorafenib in advanced clear-cell renal-cell carcinoma N Engl J Med 356 125-134

[6] Reuter VE(2005)Multiinstitutional European validation of the 2002 TNM staging system in conventional and papillary localized renal cell carcinoma Cancer 104 968-974

[7] Russo P(2002)Expression profiling in human renal carcinomas with functional taxonomic analysis BMC Bioinformatics 3 26-39

[8] Cheville JC(1994)Mutation of the VHL tumour suppressor gene in renal carcinoma Nat Genet 7 85-90

[9] Lohse CM(2005)Histologic subtyping and nuclear grading of renal cell carcinoma and their implications for Survival: a retrospective nation-wide study of 629 patients Eur Urol 48 593-600

[10] Zincke H(2007)Histologic subtype of metastatic renal cell carcinoma predicts response to combined immunochemotherapy with Interleukin 2, Interferon alpha and 5-Fluorouracil Eur Urol 51 1625-1632